These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study]. Hess G, Weber C, Rossol S, Voth R, Drees N, Meyer zum Büschenfelde KH. Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006 [Abstract] [Full Text] [Related]
69. Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial. Guarascio P, De Felici AP, Migliorini D, Alexander GJ, Fagan EA, Visco G. J Hepatol; 1986 Jul; 3 Suppl 2():S143-7. PubMed ID: 3298405 [Abstract] [Full Text] [Related]
70. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies. Scully LJ, Lever AM, Yap I, Pignatelli M, Thomas HC. J Hepatol; 1986 Jul; 3 Suppl 2():S291-9. PubMed ID: 2439575 [Abstract] [Full Text] [Related]
74. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: treatment with recombinant interferon alfa. Jonas MM, Ragin L, Silva MO. J Pediatr; 1991 Nov; 119(5):818-20. PubMed ID: 1941393 [No Abstract] [Full Text] [Related]
75. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. Perrillo RP. J Hepatol; 1986 Nov; 3 Suppl 2():S57-64. PubMed ID: 2439577 [Abstract] [Full Text] [Related]
80. Interleukins in chronic active hepatitis B. Relationship with viral markers. Civeira M, Prieto J, Morte S, Riñon M, Serrano M. J Hepatol; 1987 Aug; 5(1):37-44. PubMed ID: 3498750 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]